Contributing lab leader: Sami Yusef, Dr. Pauline Erica Tay & Dr. SaeYun Baik
Article
The integration of diagnostics and technology: Insights from global healthcare leaders
The diagnostic landscape is undergoing a profound transformation, leveraging advanced technologies to enhance disease detection and diagnosis and extend life expectancy. Health organizations are exploring innovative solutions that improve the accuracy of disease identification and advance capabilities in predicting diseases, prognosis, and continuous patient monitoring.
At Roche Experience Days (RED) 2023, three leaders in healthcare – Mr. Sami Yusef, Chair of Corporate Development, Mayo Clinic, Dr. Pauline Erica Tay, Director, National Health Innovation Centre (NHIC), Consortium for Clinical Research & Innovation Singapore (CRIS), and Dr. SaeYun Baik, Vice President & Medical Director, SCL Healthcare & Seoul Clinical Laboratories (SCL), South Korea – provided critical insights into how technology is disrupting the future of healthcare industry.
Article highlights:
- Diagnostics are adapting to the evolving healthcare landscape, influenced by the needs of physicians, payers, and patients.
- Artificial intelligence and data-driven healthcare are enabling countries to reduce chronic disease and extend life expectancy.
- Automation and robotics, digital pathology, and big data and analytics are shifting laboratory medicine and the diagnostic landscape.
Join our community and stay up to date with the latest laboratory innovations and insights.
Want to be the first to receive the latest insights from industry leaders? Sign up for our newsletter.
Contributing lab leaders
Sami Yusef
Chair, Corporate Development, Mayo Clinic
Dr. Pauline Erica Tay
Director National Health Innovation Centre (NHIC) and Consortium for Clinical Research & Innovation Singapore (CRIS)
Dr. SaeYun Baik, MD, PhD
Vice President, Medical Director
SCL Healthcare & Seoul Clinical Laboratories (SCL)
...